Posts

Showing posts from July, 2026

Import Canakinumab into India – Patient Access Steps

Image
  Canakinumab (150 mg/ml) injection available in India online For individuals living with rare autoinflammatory disorders, obtaining the right treatment can involve more than receiving a prescription. Some advanced biologic medicines are not routinely supplied through India's regular pharmaceutical distribution network, making regulated international procurement an important option for eligible patients. Canakinumab ( Ilaris ) is one such medicine. While the import process involves several administrative and regulatory steps, understanding the pathway can help patients and caregivers prepare for treatment with greater confidence. When Importing Becomes Necessary Canakinumab is not a medicine that is typically found in retail pharmacies or stocked by most healthcare facilities. As a highly specialized biologic intended for rare inflammatory disorders, its availability depends on controlled procurement rather than routine commercial distribution. Patients who require this therapy t...

Import Qalsody (Tofersen) from USA / EU to India for Individual Patients

Image
Tofersen ( Qalsody ) 100 mg injection available online in India This article mainly deals with the safe importation of Qalsody (Tofersen) to India from the approved/registered countries like the United States of America and Europe.  Import Qalsody from USA/ EU Legal access The safe and legal way to get the access from USA or European countries is through the Named Patient Program (NPP) . It is the pathway to buy Qalsody in India to the limited patients with medical need. The Drugs and Cosmetics Rules facilitates the import process for specialty medicines.  NPP extends its helping hand in the following conditions: The medicines which are approved but not approved and available in patient’s country The medicines discontinued in the patient’s country but not in another country Limited availability of medicines in patient’s country Make sure to reach out to genuine pharma product providers like 24/7QualityMeds to avoid the risk of counterfeit medicines. Determining the authenti...

Ojjaara Tablets Price and Access in India Through Named Patient Program

Image
Ojjaara (Momelotinib) 100 mg tablets available Online in India For patients living with intermediate or high-risk myelofibrosis accompanied by anemia, access to innovative therapies can significantly influence treatment outcomes. Ojjaara or Momelotinib , developed by GlaxoSmithKline (GSK), is one such advancement that has gained regulatory approvals in the United States and Europe for treating adults with myelofibrosis and anemia. The medication is specifically indicated for patients with primary myelofibrosis, post-polycythemia vera myelofibrosis and post-essential thrombocythemia myelofibrosis. The FDA-approved prescribing information recommends a standard dosage of 200 mg once daily and confirms its availability in 100 mg, 150 mg and 200 mg tablet strengths. Despite its international approvals, many patients in India wonder about Ojjaara's availability locally and how they can legally obtain it. Understanding the regulatory process can help patients and caregivers access the me...

What to Expect When Requesting Elunate (Fruquintinib) in India

Image
  Buy Fruquintinib (Elunate/Fruzaqla) tablets/ capsules online in India  For patients with refractory metastatic colorectal cancer (mCRC), treatment options become increasingly limited once the disease progresses despite standard chemotherapy and targeted therapies. In such situations, Fruquintinib ( Elunate ) has emerged as an important targeted therapy that offers a new treatment option for eligible patients. Elunate contains Fruquintinib, a highly selective oral vascular endothelial growth factor receptor or VEGFR inhibitor. It works by selectively blocking VEGFR-1, VEGFR-2, and VEGFR-3, which are responsible for the formation of new blood vessels that tumors need to grow and spread. By inhibiting these receptors, Elunate helps reduce the blood supply to tumors, thereby slowing tumor growth and disease progression. It is indicated for adults with metastatic colorectal cancer who have previously received fluoropyrimidine-, oxaliplatin-, and irinotecan-based chemot...